{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:05:00Z","timestamp":1792623900389,"version":"4.5.0"},"reference-count":306,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T00:00:00Z","timestamp":1716076800000},"content-version":"am","delay-in-days":292,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006451","name":"Hospices Civils de Lyon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006451","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.semarthrit.2023.152227","type":"journal-article","created":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T02:03:05Z","timestamp":1683943385000},"page":"152227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Joint and muscle inflammatory disease: A scoping review of the published evidence"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1202-9540","authenticated-orcid":false,"given":"Maud","family":"Lekieffre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Gallay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oc\u00e9ane","family":"Landon-Cardinal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Hot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.semarthrit.2023.152227_bib0001","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis: (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.semarthrit.2023.152227_bib0002","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis: (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0003","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","article-title":"239th ENMC International workshop: classification of dermatomyositis, amsterdam, the netherlands, 14-16 december 2018","volume":"30","author":"Mammen","year":"2020","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0004","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/WCO.0000000000000376","article-title":"Advances in serological diagnostics of inflammatory myopathies","volume":"29","author":"Benveniste","year":"2016","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC international workshop","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0006","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","article-title":"Inclusion body myositis and myopathies","volume":"38","author":"Griggs","year":"1995","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0007","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 french canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152227_bib0008","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0009","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.berh.2016.02.005","article-title":"Inflammatory myopathies and overlap syndromes: Update on histological and serological profile","volume":"29","author":"Colafrancesco","year":"2015","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0010","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s100670070030","article-title":"Clinical and serological aspects of patients with anti-jo-1 antibodies - an evolving spectrum of disease manifestations","volume":"19","author":"Schmidt","year":"2000","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0011","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12016-013-8387-6","article-title":"The evolving spectrum of polymyositis and dermatomyositis\u2014moving towards clinicoserological syndromes: a critical review","volume":"47","author":"Tansley","year":"2014","journal-title":"Clin Rev Allergy Immunol"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152227_bib0012","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11926-019-0878-x","article-title":"Arthritis in idiopathic inflammatory myopathies","volume":"21","author":"Klein","year":"2019","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0013","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3899\/jrheum.131223","article-title":"Arthritis in idiopathic inflammatory myopathy: clinical features and autoantibody associations","volume":"41","author":"Klein","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0014","doi-asserted-by":"crossref","DOI":"10.11604\/pamj.2021.38.101.25406","article-title":"Profil \u00e9pid\u00e9miologique de la dermatomyosite et de la polymyosite: exp\u00e9rience du service de rhumatologie de Marrakech","author":"Errafia","year":"2021","journal-title":"Pan Afr Med J"},{"issue":"8","key":"10.1016\/j.semarthrit.2023.152227_bib0015","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1136\/annrheumdis-2013-205127","article-title":"Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort","volume":"74","author":"Dobloug","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0016","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/1529-0131(195904)2:2<127::AID-ART1780020205>3.0.CO;2-M","article-title":"Rheumatic manifestations of polymyositis and dermatomyositis","volume":"2","author":"Pearson","year":"1959","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152227_bib0017","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00296-020-04634-0","article-title":"Trends in idiopathic inflammatory myopathies: cross-sectional data from the German National Database","volume":"40","author":"Albrecht","year":"2020","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0018","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4081\/reumatismo.2005.22","article-title":"Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients","volume":"57","author":"Ghirardello","year":"2011","journal-title":"Reumatismo"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0019","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/annrheumdis-2017-211868","article-title":"The EuroMyositis registry: an international collaborative tool to facilitate myositis research","volume":"77","author":"Lilleker","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0020","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/art.22237","article-title":"Myositis-specific and myositis-associated antibodies in a series of eighty-eight mediterranean patients with idiopathic inflammatory myopathy","volume":"55","author":"Selva-O\u2019Callaghan","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0021","first-page":"1756","article-title":"Overlap myositis, a distinct entity beyond primary inflammatory myositis: A retrospective analysis of a large cohort from the REMICAM registry","author":"Nu\u00f1o-Nu\u00f1o","year":"2019","journal-title":"Int J Rheum Dis"},{"issue":"20","key":"10.1016\/j.semarthrit.2023.152227_bib0022","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1097\/MD.0000000000000523","article-title":"In antisynthetase syndrome, ACPA are associated with severe and erosive arthritis: an overlapping rheumatoid arthritis and antisynthetase syndrome","volume":"94","author":"Meyer","year":"2015","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0023","first-page":"44","article-title":"Timing of onset affects arthritis presentation pattern in antisyntethase syndrome","volume":"36","author":"Gonz\u00e1lez-Gay","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0024","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/0970-2113.173055","article-title":"Antisynthetase syndrome: an under-recognized cause of interstitial lung disease","volume":"33","author":"Maturu","year":"2016","journal-title":"Lung India"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0025","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/1756-185X.14105","article-title":"Clinical characteristics of Vietnamese patients with idiopathic inflammatory myopathies and autoantibodies to aminoacyl-transfer RNA synthetases","volume":"24","author":"Phuong","year":"2021","journal-title":"Int J Rheum Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2023.152227_bib0026","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.3390\/jcm8112013","article-title":"Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course","volume":"8","author":"Cavagna","year":"2019","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0027","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.autrev.2017.01.008","article-title":"Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study","volume":"16","author":"Bartoloni","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0028","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.12659\/AJCR.916178","article-title":"Antisynthetase syndrome and autoantibodies: a literature review and report of 4 cases","volume":"20","author":"Marin","year":"2019","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/6416378","article-title":"Effect of genetic and laboratory findings on clinical course of antisynthetase syndrome in a hungarian cohort","volume":"2018","author":"Szab\u00f3","year":"2018","journal-title":"BioMed Res Int"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0030","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/08916930600623767","article-title":"Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies","volume":"39","author":"Mielnik","year":"2006","journal-title":"Autoimmunity"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0031","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/art.22506","article-title":"Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase","volume":"56","author":"Hirakata","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0032","doi-asserted-by":"crossref","first-page":"1060.1","DOI":"10.3899\/jrheum.141470","article-title":"Anti-Jo1 antibody in polymyositis\/dermatomyositis is still closely associated with lung rather than joints","volume":"42","author":"Jearn","year":"2015","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0033","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/ard.37.5.397","article-title":"The arthritis of mixed connective tissue disease","volume":"37","author":"Bennett","year":"1978","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0034","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ard.38.1.74","article-title":"Clinical significance of antibodies to ribonucleoprotein","volume":"38","author":"Cohen","year":"1979","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152227_bib0035","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/rheumatology\/31.12.811","article-title":"Clinical manifestations and anti-(U1)snRNP antibodies: a prospective study of 29 anti-RNP antibody positive patients","volume":"31","author":"Lundberg","year":"1992","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0036","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00005792-198901000-00004","article-title":"Clinical and serologic characteristics of patients with overlap syndrome: is mixed connective tissue disease a distinct clinical entity?","volume":"68","author":"L\u00e1zaro","year":"1989","journal-title":"Medicine"},{"issue":"1-2","key":"10.1016\/j.semarthrit.2023.152227_bib0037","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5144\/0256-4947.2002.43","article-title":"Mixed connective tissue disease: the king faisal specialist hospital experience","volume":"22","author":"Rayes","year":"2002","journal-title":"Ann Saudi Med"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152227_bib0038","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/rheumatology\/41.9.1040","article-title":"Inflammatory myositis associated with anti-U1-small nuclear ribonucleoprotein antibodies: a subset of myositis associated with a favourable outcome","volume":"41","author":"Coppo","year":"2002","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0039","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.berh.2007.10.002","article-title":"Mixed connective tissue disease: what is behind the curtain?","volume":"21","author":"Aringer","year":"2007","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"13","key":"10.1016\/j.semarthrit.2023.152227_bib0040","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1177\/0961203312456751","article-title":"Distinct phenotypes in mixed connective tissue disease: subgroups and survival","volume":"21","author":"Szodoray","year":"2012","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0041","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.berh.2016.03.002","article-title":"Mixed connective tissue disease","volume":"30","author":"Gunnarsson","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"13","key":"10.1016\/j.semarthrit.2023.152227_bib0042","doi-asserted-by":"crossref","first-page":"e1416","DOI":"10.1212\/WNL.0000000000007188","article-title":"Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies","volume":"92","author":"Casal-Dominguez","year":"2019","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152227_bib0043","first-page":"1511","article-title":"Clinical course of patients with anti-RNP antibodies. a prospective study of 32 patients","volume":"18","author":"Lundberg","year":"1991","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0044","first-page":"563","article-title":"Clinical and serological associations of anti-Ku antibody","volume":"26","author":"Cooley","year":"1999","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152227_bib0045","first-page":"1393","article-title":"Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients","volume":"29","author":"Franceschini","year":"2002","journal-title":"J Rheumatol"},{"issue":"2 Suppl 76","key":"10.1016\/j.semarthrit.2023.152227_bib0046","first-page":"118","article-title":"A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies","volume":"31","author":"Cavazzana","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2023.152227_bib0047","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/0961203308089442","article-title":"Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases","volume":"17","author":"Cavazzana","year":"2008","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152227_bib0048","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1136\/ard.2007.073981","article-title":"Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study","volume":"67","author":"Rozman","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102465","article-title":"Anti-RNP antibodies delineate a subgroup of myositis: A systematic retrospective study on 46 patients","volume":"19","author":"Wesner","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"23","key":"10.1016\/j.semarthrit.2023.152227_bib0050","doi-asserted-by":"crossref","first-page":"e2068","DOI":"10.1212\/WNL.0000000000005638","article-title":"Muscular and extramuscular clinical features of patients with anti-PM\/Scl autoantibodies","volume":"90","author":"De Lorenzo","year":"2018","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0051","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00005792-199211000-00001","article-title":"The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl","volume":"71","author":"Marguerie","year":"1992","journal-title":"Medicine"},{"issue":"8","key":"10.1016\/j.semarthrit.2023.152227_bib0052","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/acr.21992","article-title":"Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum: clinical features of anti-MDA-5-positive patients","volume":"65","author":"Hall","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"11","key":"10.1016\/j.semarthrit.2023.152227_bib0053","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00296-019-04398-2","article-title":"Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review","volume":"39","author":"Huang","year":"2019","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0054","article-title":"Anti-Jo-1 syndrome often misdiagnosed as rheumatoid arthritis (for many years): a single-center experience","author":"Kumar","year":"2019","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0055","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4081\/reumatismo.2020.1275","article-title":"The clinical manifestations at the onset of antisynthetase syndrome: a chameleon with multiple faces","volume":"72","author":"Baccaro","year":"2020","journal-title":"Reumatismo"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0056","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12016-016-8528-9","article-title":"Serum Jo-1 autoantibody and isolated arthritis in the antisynthetase syndrome: review of the literature and report of the experience of AENEAS collaborative group","volume":"52","author":"Cavagna","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0057","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.semarthrit.2016.03.011","article-title":"Clinical manifestations and long-term outcome of anti-Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group","volume":"46","author":"Trallero-Aragu\u00e1s","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152227_bib0058","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00296-011-1931-x","article-title":"High Frequencies and co-existing of myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies overlapped to rheumatoid arthritis","volume":"32","author":"Nakajima","year":"2012","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0059","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.autrev.2012.06.004","article-title":"Overlap connective tissue disease syndromes","volume":"12","author":"Iaccarino","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0060","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0248-8663(96)81436-6","article-title":"Association polymyosite et polyarthite rhumato\u00efde. \u00c0 propos d'une nouvelle observation non li\u00e9e \u00e0 une prise m\u00e9dicamenteuse","volume":"17","author":"Jardin","year":"1996","journal-title":"Rev M\u00e9de Interne"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0061","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s002960000084","article-title":"Association of polymyositis with rheumatoid arthritis","volume":"20","author":"Mart\u00ednez-Cordero","year":"2001","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0062","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/ard.25.2.127","article-title":"Polymyositis in rheumatoid arthritis","volume":"25","author":"Pitkeathly","year":"1966","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152227_bib0063","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American college of Rheumatology\/European league against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0064","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00296-009-1222-y","article-title":"Development of antisynthetase syndrome in a patient with rheumatoid arthritis","volume":"31","author":"Park","year":"2011","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0065","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10067-010-1666-1","article-title":"A case of antisynthetase syndrome in a rheumatoid arthritis patient with anti-PL-12 antibody following treatment with etanercept","volume":"30","author":"Ishikawa","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/179180","article-title":"New onset of dermatomyositis\/polymyositis during Anti-TNF- \u03b1 therapies: a systematic literature review","volume":"2014","author":"Brunasso","year":"2014","journal-title":"Sci World J"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0067","doi-asserted-by":"crossref","DOI":"10.1001\/archdermatol.2010.142","article-title":"Tumor necrosis factor inhibitor-associated dermatomyositis","author":"Klein","year":"2010","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0068","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.rbr.2015.12.005","article-title":"Three cases of anti-TNF induced myositis and literature review","volume":"57","author":"Zengin","year":"2017","journal-title":"Rev Bras Reumatol Engl Ed"},{"issue":"11","key":"10.1016\/j.semarthrit.2023.152227_bib0069","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.nmd.2020.09.026","article-title":"Adalimumab and myositis: a case report and review of the french and international pharmacovigilance databases","volume":"30","author":"Gaboriau","year":"2020","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0070","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","article-title":"Autoimmune Diseases Induced by TNF-Targeted Therapies: Analysis of 233 Cases","volume":"86","author":"Ramos-Casals","year":"2007","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152227_bib0071","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.7326\/0003-4819-13-12-2265","article-title":"Felty\u2019s syndrome; its several features, including tissue changes, compared with other forms of rheumatoid arthritis","volume":"13","author":"Curtis","year":"1940","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152227_bib0072","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/art.1780270703","article-title":"Rheumatoid myositis","volume":"27","author":"Halla","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0073","article-title":"Neuromuscular disorders in rheumatoid arthritis: a motor-point muscle biopsy study","author":"Haslock","year":"1970","journal-title":"QJM Int J Med"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0074","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/ard.22.5.342","article-title":"Muscular changes in rheumatoid arthritis","volume":"22","author":"Yates","year":"1963","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/01913120050132886","article-title":"Muscle involvement in rheumatoid arthritis: an ultrastructural study","volume":"24","author":"De Palma","year":"2000","journal-title":"Ultrastruct Pathol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0076","first-page":"103","article-title":"Lesions of skeletal muscles in rheumatoid arthritis: nodular polymyositis","volume":"22","author":"Steiner","year":"1946","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0077","first-page":"865","article-title":"Peripheral nerves in chronic atrophic arthritis","volume":"18","author":"Freund","year":"1942","journal-title":"Am J Pathol"},{"issue":"155","key":"10.1016\/j.semarthrit.2023.152227_bib0078","first-page":"335","article-title":"Neuromuscular disorders in rheumatoid arthritis. a motor-point muscle biopsy study","volume":"39","author":"Haslock","year":"1970","journal-title":"Q J Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0079","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00000441-195002000-00008","article-title":"Diagnostic value of histologic lesions of striated muscle in rheumatoid arthritis","volume":"219","author":"Sokoloff","year":"1950","journal-title":"Am J Med Sci"},{"issue":"1-2","key":"10.1016\/j.semarthrit.2023.152227_bib0080","first-page":"95","article-title":"Plasma cell myositis in rheumatoid arthritis","volume":"31","author":"Magyar","year":"1974","journal-title":"Acta Med Acad Sci Hung"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0081","first-page":"223","article-title":"Immunohistochemical study of skeletal muscle in rheumatoid myositis","volume":"50","author":"Ancu\u0163a","year":"2009","journal-title":"Rom J Morphol Embryol"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0082","first-page":"781","article-title":"Rheumatoid myositis, myth or reality? A clinical, imaging and histological study","volume":"55","author":"Ancu\u0163a","year":"2014","journal-title":"Rom J Morphol Embryol"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0083","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0007-1226(68)80062-1","article-title":"Interosseous muscle biopsy during hand surgery for rheumatoid arthritis","volume":"21","author":"Riley","year":"1968","journal-title":"Br J Plast Surg"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0084","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/XEB.0000000000000277","article-title":"Updated methodological guidance for the conduct of scoping reviews","volume":"19","author":"Peters","year":"2021","journal-title":"JBI Evid Implement"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152227_bib0085","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0086","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/ard.5.4.131","article-title":"Lesions in muscle in arthritis","volume":"5","author":"Gibson","year":"1946","journal-title":"Ann Rheum Dis"},{"issue":"sup12","key":"10.1016\/j.semarthrit.2023.152227_bib0087","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/rhe1.1968.13.suppl-12.01","article-title":"Certain muscular diseases in patients with rheumatoid arthritis","volume":"13","author":"Strandberg","year":"1968","journal-title":"Acta Rheumatol Scand"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0088","first-page":"101","article-title":"Muscle pathology in rheumatoid arthritis, polymyalgia rheumatica, and polymyositis: a histochemical study","volume":"94","author":"Brooke","year":"1972","journal-title":"Arch Pathol"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0089","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00432241","article-title":"Muscle changes in rheumatoid arthritis: a review of the literature with a study of 100 cases","volume":"373","author":"Magyar","year":"1977","journal-title":"Virchows Arch A Pathol Anat Histol"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0090","first-page":"552","article-title":"Ultrastructure of skeletal muscle in rheumatoid myositis","volume":"15","author":"Finol","year":"1988","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0091","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0049-0172(96)80007-2","article-title":"Muscle involvement in rheumatoid arthritis:Clinicopathological study of 21 symptomatic cases","volume":"25","author":"Mir\u00f3","year":"1996","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0092","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/01.rhu.0000152149.34252.2e","article-title":"Severe proximal myopathy and mononeuritis multiplex in rheumatoid arthritis: manifestations of rheumatoid vasculitis","volume":"11","author":"Chatterjee","year":"2005","journal-title":"JCR J Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152227_bib0093","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s10067-014-2657-4","article-title":"Rheumatoid myositis leading to acute lower extremity compartment syndrome: a case-based review","volume":"34","author":"Jo","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0094","first-page":"646","article-title":"Perineuritic and polymyositic granulomatous nodules in rheumatoid arthritis","volume":"22","author":"Steiner","year":"1946","journal-title":"Am J Pathol"},{"issue":"7673","key":"10.1016\/j.semarthrit.2023.152227_bib0095","first-page":"600","article-title":"Neuromuscular disorders in rheumatoid arthritis","volume":"2","year":"1970","journal-title":"Lancet Lond Engl"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0096","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/01913120050132886","article-title":"Muscle involvement in rheumatoid arthritis: an ultrastructural study","volume":"24","author":"Luigi De Palma","year":"2000","journal-title":"Ultrastruct Pathol"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0097","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0002-9343(56)90130-9","article-title":"Arthritis, polymyositis and polyneuritis","volume":"20","author":"Amoz","year":"1956","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0098","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/1529-0131(195912)2:6<499::AID-ART1780020605>3.0.CO;2-G","article-title":"Dermatomyositis, disseminated calcinosis and metaplastic ossification\u2013clinical studies over a period of 7 years in a female with rheumatoid arthritis","volume":"2","author":"Talbott","year":"1959","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0099","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2106\/00004623-197658040-00027","article-title":"Rheumatoid arthritis with unusual myositis resembling muscular dystrophy","volume":"58","author":"Labbate","year":"1976","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/art.1780190217","article-title":"Deforming arthritis of the hands in polymyositis","volume":"19","author":"Bunch","year":"1976","journal-title":"Arthritis Rheum"},{"issue":"27","key":"10.1016\/j.semarthrit.2023.152227_bib0101","first-page":"2427","article-title":"[Primary biliary cirrhosis associated with rheumatoid arthritis and acute polymyositis]","volume":"6","author":"Benoist","year":"1977","journal-title":"Nouv Presse Med"},{"issue":"8","key":"10.1016\/j.semarthrit.2023.152227_bib0102","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s10067-014-2730-z","article-title":"Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis","volume":"33","author":"Aguila","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2023.152227_bib0103","first-page":"1572.1","article-title":"AB0552 Characteristics of myositis spetrum disease - rheumatoid arthritis overlap cases in a hungarian cohort","volume":"79","author":"Bodoki","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0104","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1590\/S0004-282X2000000100027","article-title":"Orbital myositis and rheumatoid arthritis: case report","volume":"58","author":"Panfilio","year":"2000","journal-title":"Arq Neuropsiquiatr"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152227_bib0105","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/ard.61.10.938","article-title":"A case of orbital myositis associated with rheumatoid arthritis","volume":"61","author":"Nabili","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2023.152227_bib0106","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0248-8663(04)00274-7","article-title":"Atteinte des muscles oculomoteurs r\u00e9v\u00e9lant une dermatomyosite chez une patiente ayant une polyarthrite rhumato\u00efde","volume":"25","author":"Younes","year":"2004","journal-title":"Rev M\u00e9d Interne"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152227_bib0107","first-page":"1457","article-title":"Nonerosive metacarpophalangeal arthritides in a patient with dermatomyositis","volume":"31","author":"Schedel","year":"2004","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0108","first-page":"362","article-title":"Development of polymyositis after long-standing rheumatoid arthritis","volume":"33","author":"Rohekar","year":"2006","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0109","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jbspin.2009.08.008","article-title":"Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: Relevance for clinical classification: Retrospective study of 169 patients","volume":"77","author":"V\u00e1ncsa","year":"2010","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0110","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s10067-011-1754-x","article-title":"Moderate incidence of prior rheumatoid arthritis in patients with polymyositis and dermatomyositis","volume":"30","author":"Nagashima","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0111","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0002-9343(79)90404-2","article-title":"Articular manifestations of polymyositis and dermatomyositis","volume":"67","author":"Schumacher","year":"1979","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0112","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2214\/ajr.136.3.611","article-title":"Deforming arthritis of the hands: an unusual manifestation of polymyositis","volume":"136","author":"Greenway","year":"1981","journal-title":"Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0113","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/014107688107400518","article-title":"Penicillamine-induced dermatomyositis","volume":"74","author":"Major","year":"1981","journal-title":"J R Soc Med"},{"issue":"27","key":"10.1016\/j.semarthrit.2023.152227_bib0114","first-page":"1695","article-title":"[Polymyositis occurring during the development of rheumatoid arthritis]","volume":"13","author":"Castela","year":"1984","journal-title":"Presse Medicale Paris Fr 1983"},{"issue":"29","key":"10.1016\/j.semarthrit.2023.152227_bib0115","first-page":"1564","article-title":"[Polymyositis as a sequela of inactive rheumatoid arthritis]","volume":"14","author":"Eschard","year":"1985","journal-title":"Presse Medicale Paris Fr 1983"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0116","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/rheumatology\/27.2.146","article-title":"coexistence of rheumatoid arthritis, ankylosing spondylitis and dermatomyositis in a patient with diabetes mellitus and the associated linked HLA antigens","volume":"27","author":"Sattar","year":"1988","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0117","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02230338","article-title":"Facioscapulohumeral dystrophy with myositis associated with rheumatoid arthritis","volume":"15","author":"Coelho","year":"1996","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0118","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10067-004-0903-x","article-title":"Antiphospholipid and antisynthetase syndrome in a patient with polymyositis-rheumatoid arthritis overlap","volume":"23","author":"Ponyi","year":"2004","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0119","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/brain\/98.4.637","article-title":"Polymyositis: its presentation, morbidity and mortality","volume":"98","author":"Devere","year":"1975","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","article-title":"A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis","volume":"56","author":"Bohan","year":"1977","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0121","first-page":"1140","article-title":"Dermatopolymyositis and other connective tissue diseases: a review of 105 cases","volume":"12","author":"Tymms","year":"1985","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0122","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/art.1780280303","article-title":"Prognostic factors in polymyositis\/dermatomyositis. A computer-assisted analysis of ninety-two cases","volume":"28","author":"Benbassat","year":"1985","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0123","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0049-0172(90)90024-A","article-title":"Adult-onset polymyositis-dermatomyositis: Description of 25 patients with emphasis on treatment","volume":"20","author":"Ram\u00edrez","year":"1990","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152227_bib0124","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/ard.52.12.857","article-title":"Adult onset polymyositis\/dermatomyositis: clinical and laboratory features and treatment response in 75 patients","volume":"52","author":"Koh","year":"1993","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0125","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0049-0172(96)80025-4","article-title":"Distinctive features of idiopathic inflammatory myopathies in French Canadians","volume":"26","author":"Uthman","year":"1996","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0126","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4103\/0972-2327.74190","article-title":"Clinical, electrophysiologic, and histopathologic profile, and outcome in idiopathic inflammatory myositis: An analysis of 68 cases","volume":"13","author":"Kuruvilla","year":"2010","journal-title":"Ann Indian Acad Neurol"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152227_bib0127","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s00296-019-04411-8","article-title":"Prevalence of other connective tissue diseases in idiopathic inflammatory myopathies","volume":"39","author":"Maundrell","year":"2019","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0128","series-title":"Profile of various idiopathic inflammatory myopathies at two university hospitals in Yangon, Myanmar","first-page":"285","author":"Ohnmar","year":"2020"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152227_bib0129","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s10067-007-0562-9","article-title":"Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study","volume":"26","author":"Ye","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0130","doi-asserted-by":"crossref","DOI":"10.1136\/bjo.83.5.e628","article-title":"Unilateral ptosis due to isolated involvement of the levator muscle in acute orbital myositis","volume":"83","author":"Wheatcroft","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0131","article-title":"Seropositive Rheumatoid Arthritis Associated Myositis Presenting with Dysphagia and Dysarthria","author":"O'Neil","year":"2017","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0132","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00296-020-04779-y","article-title":"Characteristics and outcomes of overlap myositis: a comparative multigroup cohort study in adults from the MyoCite cohort","volume":"41","author":"Naveen","year":"2021","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0133","first-page":"344","article-title":"Inclusion body myositis in association with rheumatoid arthritis","volume":"21","author":"Soden","year":"1994","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0134","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10067-009-1367-9","article-title":"Inclusion body myositis in a patient with long standing rheumatoid arthritis treated with anti-TNF\u03b1 and rituximab","volume":"29","author":"Vordenb\u00e4umen","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0135","unstructured":"Clerici A., Bono G., Delodovici M., Azan G., Cafasso G., Micieli G. A rare association of early-onset inclusion body myositis, rheumatoid arthritis and autoimmune thyroiditis: a case report and literature review. Funct Neurol."},{"key":"10.1016\/j.semarthrit.2023.152227_bib0136","doi-asserted-by":"crossref","DOI":"10.1093\/rap\/rky046","article-title":"Inclusion body myositis in a patient with rheumatoid arthritis","author":"Tariq","year":"2018","journal-title":"Rheumatol Adv Pract"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0137","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.semarthrit.2019.11.008","article-title":"Concurrent anti-PM-Scl antibody-associated systemic sclerosis and inclusion body myositis - report of two cases and review of the literature","volume":"50","author":"Chatterjee","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0138","doi-asserted-by":"crossref","DOI":"10.1177\/2040622320968417","article-title":"Interstitial lung disease is a major characteristic of anti-KS associated ant-synthetase syndrome","volume":"11","author":"Ge","year":"2020","journal-title":"Ther Adv Chronic Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0139","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.autrev.2012.06.006","article-title":"Hierarchical cluster and survival analyses of antisynthetase syndrome: Phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity","volume":"12","author":"Hervier","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0140","first-page":"2315","article-title":"Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease","volume":"162","author":"Hirakata","year":"1999","journal-title":"J Immunol Baltim Md 1950"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0141","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/art.1780350415","article-title":"Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in japanese patients with inflammatory muscle disease","volume":"35","author":"Hirakata","year":"1992","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152227_bib0142","first-page":"483","article-title":"Antisynthetase syndrome. Three cases and a review of the literature","volume":"154","author":"Imbert-Masseau","year":"2003","journal-title":"Ann Med Interne"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0143","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/rheumatology\/kex021","article-title":"A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies","volume":"56","author":"Pinal-Fernandez","year":"2017","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0144","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/BF02201038","article-title":"Interstitial lung disease as the presentation of anti-Jo-1 positive polymyositis","volume":"6","author":"Nash","year":"1987","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0145","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0002-9343(90)90149-8","article-title":"Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase)","volume":"88","author":"Targoff","year":"1990","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.semarthrit.2023.152227_bib0146","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/art.1780331106","article-title":"A subluxing arthropathy associated with the anti-jo-1 antibody in polymyositis\/dermatomyositis","volume":"33","author":"Oddis","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0147","first-page":"141","article-title":"Rheumatoid arthritis associated with myositis and anti-Jo-1 antibody","volume":"20","author":"O'Neill","year":"1993","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152227_bib0148","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/art.1780361215","article-title":"Idiopathic inflammatory myopathy of the antisynthetase (jo-1) type associated with noncaseating granulomas","volume":"36","author":"Moder","year":"1993","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152227_bib0149","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0248-8663(05)81248-2","article-title":"Polyarthrite aigu\u00eb, fibrose pulmonaire et ph\u00e9nom\u00e8ne de Raynaud r\u00e9v\u00e9lant une polymyosite avec anticorps anti-JO-1 associ\u00e9e \u00e0 un syndrome de Gougerot-Sj\u00f6gren","volume":"14","author":"Cardon","year":"1993","journal-title":"Rev M\u00e9decine Interne"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152227_bib0150","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/rheumatology\/32.10.929","article-title":"Idiopathic polymyositis complicated by arthritis and mesangial proliferative glomerulonephritis: case report and review of the literature","volume":"32","author":"Frost","year":"1993","journal-title":"Br J Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152227_bib0151","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/art.1780381020","article-title":"Adult respiratory distress syndrome in polymyositis patients with the anti-jo-1 antibody","volume":"38","author":"Clawson","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0152","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.1780390424","article-title":"Coexistence of two antisynthetases in a patient with the antisynthetase syndrome","volume":"39","author":"Gelp\u00ed","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152227_bib0153","first-page":"2693","article-title":"Dermatomyositis with erosive arthropathy: association with the anti-PL-7 antibody","volume":"26","author":"Wasko","year":"1999","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0154","first-page":"1401","article-title":"Periarticular calcinosis associated with anti-Jo-1 antibodies sine myositis. Expanding the clinical spectrum of the antisynthetase syndrome","volume":"28","author":"Queiro-Silva","year":"2001","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0155","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1297-319X(01)00258-5","article-title":"Arthropathy associated with anti-Jo-1 antibody","volume":"68","author":"Delbrel","year":"2001","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0156","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0248-8663(01)00552-5","article-title":"Le syndrome des anti-synth\u00e9tases\u00a0: un sous-groupe des myopathies inflammatoires \u00e0 ne pas m\u00e9conna\u00eetre","volume":"23","author":"Legout","year":"2002","journal-title":"Rev M\u00e9decine Interne"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0157","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1297-319X(01)00345-1","article-title":"Dermatomyositis sine myositis and antisynthetase syndrome","volume":"69","author":"Climent-Albaladejo","year":"2002","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0158","first-page":"371","article-title":"[The anti-synthetase syndrome]","volume":"19","author":"Bergoin","year":"2002","journal-title":"Rev Mal Respir"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0159","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/039463200401700320","article-title":"Association of myasthenia gravis and antisynthetase syndrome: a case report","volume":"17","author":"Diaco","year":"2004","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/08916930600623874","article-title":"Anti-Jo-1 antibody positive polymyositis\u2014successful therapy with leflunomide","volume":"39","author":"Lange","year":"2006","journal-title":"Autoimmunity"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0161","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/rheumatology\/kel435","article-title":"Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies","volume":"46","author":"Sato","year":"2007","journal-title":"Rheumatol Oxf Engl"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152227_bib0162","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.3899\/jrheum.090183","article-title":"Destructive arthropathy associated with dermatomyositis sine myositis positive for anti-Jo-1 and anti-cyclic citrullinated peptide antibodies","volume":"36","author":"Nagashima","year":"2009","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0163","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jbspin.2009.10.007","article-title":"Antisynthetases syndrome associated with right heart failure","volume":"76","author":"Tahiri","year":"2009","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0164","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/03009740600902437","article-title":"A patient with antisynthetase syndrome associated with deforming arthritis and periarticular calcinosis sine myositis","volume":"36","author":"\u00d6zt\u00fcrk","year":"2007","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152227_bib0165","doi-asserted-by":"crossref","first-page":"1967.2","DOI":"10.3899\/jrheum.091402","article-title":"Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome","volume":"37","author":"Cavagna","year":"2010","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152227_bib0166","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/RHU.0b013e3181f3bf9c","article-title":"Antisynthetase syndrome presenting as rheumatoid-like polyarthritis","volume":"16","author":"Mumm","year":"2010","journal-title":"JCR J Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0167","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00296-010-1467-5","article-title":"Antisynthetase syndrome associated with long-standing rheumatoid arthritis","volume":"31","author":"Nagashima","year":"2011","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0168","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.pneumo.2011.01.003","article-title":"Pneumopathie interstitielle aigu\u00eb r\u00e9v\u00e9latrice d'un syndrome des antisynth\u00e9tases","volume":"67","author":"Bizien","year":"2011","journal-title":"Rev Pneumol Clin"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0169","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1378\/chest.11-2643","article-title":"47-year-old woman with worsening dyspnea, arthritis, and muscle pain","volume":"142","author":"Merchant","year":"2012","journal-title":"Chest"},{"issue":"22","key":"10.1016\/j.semarthrit.2023.152227_bib0170","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1056\/NEJMcpc1208147","article-title":"Case 37-2012: A 21-year-old man with fevers, arthralgias, and pulmonary infiltrates","volume":"367","author":"Christopher-Stine","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0171","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.resinv.2012.04.003","article-title":"A case of interstitial lung disease with anti-EJ and anti-CCP antibodies preceding rheumatoid arthritis","volume":"50","author":"Tomioka","year":"2012","journal-title":"Respir Investig"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0172","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.pneumo.2012.07.002","article-title":"Le syndrome des antisynth\u00e9tases\u00a0: \u00e0 propos de quatre observations et revue de la litt\u00e9rature","volume":"68","author":"Frikha","year":"2012","journal-title":"Rev Pneumol Clin"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0173","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2340\/00015555-1744","article-title":"Annular erythema associated with sj\u00f6gren's syndrome preceding overlap syndrome of rheumatoid arthritis and polymyositis with anti-PL-12 autoantibodies","volume":"94","author":"Sugiura","year":"2014","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0174","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3109\/14397595.2013.874741","article-title":"Anti-Jo-1 myositis and the antiphospholipid syndrome showing right ventricular thrombus: a novel overlap syndrome with atypical presentation","volume":"24","author":"Wang","year":"2014","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0175","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13256-015-0571-2","article-title":"Mechanic's hands in a woman with undifferentiated connective tissue disease and interstitial lung disease - anti-PL7 positive antisynthetase syndrome: a case report","volume":"9","author":"De Langhe","year":"2015","journal-title":"J Med Case Reports"},{"issue":"8","key":"10.1016\/j.semarthrit.2023.152227_bib0176","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/acr.22781","article-title":"Respiratory Distress and Nephropathy in a Young Male With Small-Joint Polyarthritis: Clinicopathologic Conference","volume":"68","author":"Korsten","year":"2016","journal-title":"Arthritis Care Res"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0177","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jbspin.2015.10.014","article-title":"Rheumatoid arthritis and antisynthetase syndrome. a three cases report","volume":"83","author":"Wendling","year":"2016","journal-title":"Joint Bone Spine"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152227_bib0178","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1007\/s10067-016-3258-1","article-title":"Heterogeneous clinical spectrum of interstitial lung disease in patients with anti-EJ anti-synthetase syndrome: a case series","volume":"35","author":"Giannini","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0179","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17843286.2017.1403133","article-title":"64-year-old woman with interstitial lung disease and positive antibodies against aminoacyl-transfer RNA synthetases in the absence of myositis: presentation of an anti-PL-12 positive antisynthetase syndrome","author":"Ghysen","year":"2017","journal-title":"Acta Clin Belg"},{"issue":"1.2","key":"10.1016\/j.semarthrit.2023.152227_bib0180","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2152\/jmi.65.147","article-title":"A case of interstitial pneumonia associated with anti-PL-7 antibody in a patient with rheumatoid arthritis","volume":"65","author":"Kozai","year":"2018","journal-title":"J Med Investig JMI"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0181","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5606\/ArchRheumatol.2018.6401","article-title":"The association of anti-aminoacyl-transfer ribonucleic acid synthetase antibodies in patients with rheumatoid arthritis and interstitial lung disease","volume":"33","author":"Matsushita","year":"2018","journal-title":"Arch Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0182","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5152\/eurjrheum.2018.17167","article-title":"Novel case of anti-synthetase syndrome","volume":"5","author":"Kapoor","year":"2018","journal-title":"Eur J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0183","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5114\/reum.2020.93505","article-title":"The clinical phenotype associated with antisynthetase autoantibodies","volume":"58","author":"Masiak","year":"2020","journal-title":"Reumatol Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0184","first-page":"1","article-title":"PL-7 antisynthetase syndrome in association with sj\u00f6gren\u2019s, systemic lupus erythematosus, and rheumatoid arthritis","volume":"2020","author":"Jawaid","year":"2020","journal-title":"Case Rep Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0185","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/24725625.2020.1794521","article-title":"Antisynthetase syndrome and pulmonary hypertension: report of two cases and review of the literature","volume":"5","author":"Garc\u00eda-Fern\u00e1ndez","year":"2021","journal-title":"Mod Rheumatol Case Rep"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0186","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.amjms.2020.11.012","article-title":"65-year-old woman with persistent dyspnea, arthritis, and raynaud's phenomenon","volume":"361","author":"Chong","year":"2021","journal-title":"Am J Med Sci"},{"issue":"30","key":"10.1016\/j.semarthrit.2023.152227_bib0187","first-page":"1423","article-title":"[Deforming arthropathy associated with the presence of anti Jo-1 antibody in polymyositis. A new case]","volume":"21","author":"Lifermann","year":"1992","journal-title":"Presse Med Paris Fr 1983"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152227_bib0188","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/rheumatology\/kez504","article-title":"The myositis clinical phenotype associated with anti-Zo autoantibodies: a case series of nine UK patients","volume":"59","author":"Tansley","year":"2020","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0189","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s10067-019-04471-y","article-title":"Sonographic findings from inflammatory arthritis due to antisynthetase syndrome","volume":"38","author":"Miller","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0190","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/rheumatology\/keu404","article-title":"Seronegative polyarthritis revealing antisynthetase syndrome: a multicentre study of 40 patients","volume":"54","author":"Lef\u00e8vre","year":"2015","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152227_bib0191","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1445-5994.2010.02164.x","article-title":"Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies: Anti-synthetase syndrome","volume":"41","author":"Dugar","year":"2011","journal-title":"Intern Med J"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0192","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/qjmed\/77.1.1019","article-title":"Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-trna synthetase enzymes","volume":"77","author":"Marguerie","year":"1990","journal-title":"QJM"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0193","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/art.21883","article-title":"Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis\/dermatomyositis","volume":"54","author":"Yamasaki","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0194","first-page":"609","article-title":"Clinical characteristics of Japanese patients with anti-PL-7 (anti-threonyl-tRNA synthetase) autoantibodies","volume":"23","author":"Sato","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0195","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1196\/annals.1398.047","article-title":"Clinical significance of anti-histidyl-tRNA synthetase (Jo1) autoantibodies","volume":"1109","author":"Gomard-Mennesson","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0196","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.semarthrit.2011.09.008","article-title":"Short-term and long-term outcome of anti-jo1-positive patients with anti-Ro52 antibody","volume":"41","author":"Marie","year":"2012","journal-title":"Semin Arthritis Rheum"},{"issue":"32","key":"10.1016\/j.semarthrit.2023.152227_bib0197","doi-asserted-by":"crossref","first-page":"e1144","DOI":"10.1097\/MD.0000000000001144","article-title":"Clinical spectrum time course in anti jo-1 positive antisynthetase syndrome: results from an international retrospective multicenter study","volume":"94","author":"Cavagna","year":"2015","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0198","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MD.0b013e318260977c","article-title":"Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a european multicenter study (eumyonet) and review of the literature","volume":"91","author":"Labirua-Iturburu","year":"2012","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0199","doi-asserted-by":"crossref","DOI":"10.7860\/JCDR\/2016\/16872.7361","article-title":"Antisynthetase syndrome: a rare cause for ILD","author":"Devi","year":"2016","journal-title":"J Clin Diagn Res"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11926-011-0176-8","volume":"13","author":"Katzap","year":"2011","journal-title":"Curr Rheumatol Rep"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152227_bib0201","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3949\/ccjm.80a.12171","article-title":"Antisynthetase syndrome: not just an inflammatory myopathy","volume":"80","author":"Chatterjee","year":"2013","journal-title":"Cleve Clin J Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0202","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.rmr.2014.07.013","article-title":"Les manifestations pulmonaires du syndrome des antisynth\u00e9tases","volume":"32","author":"Jouneau","year":"2015","journal-title":"Rev Mal Respir"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0203","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/BOR.0000000000000434","article-title":"Clinical spectrum of anti-Jo-1-associated disease","volume":"29","author":"Monti","year":"2017","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0204","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/15563650.2020.1817479","article-title":"Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose","volume":"59","author":"Doyno","year":"2021","journal-title":"Clin Toxicol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0205","doi-asserted-by":"crossref","first-page":"615","DOI":"10.7326\/0003-4819-85-5-615","article-title":"D-penicillamine-induced polymyositis in rheumatoid arthritis","volume":"85","author":"Cucher","year":"1976","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0206","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/ard.36.1.94","article-title":"Dermatomyositis complicating penicillamine treatment","volume":"36","author":"Fernandes","year":"1977","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0207","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/03009747809098847","article-title":"Penicillamine-inducedpolymyositis-dermatomyositis","volume":"7","author":"Petersen","year":"1978","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0208","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/art.1780230322","article-title":"Polymyositis with acute myolysis in a patient with rheumatoid arthritis treated with penicillamine and ampicillin","volume":"23","author":"\u00d8tensen","year":"1980","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152227_bib0209","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1177\/014107688007301213","article-title":"Dermatomyositis induced by penicillamine","volume":"73","author":"Wojnarowska","year":"1980","journal-title":"J R Soc Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mus.880040210","article-title":"Penicillamine-induced myositis in rheumatoid arthritis","volume":"4","author":"Morgan","year":"1981","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152227_bib0211","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1097\/00007611-198110000-00042","article-title":"Penicillamine-induced polymyositis in a patient with rheumatoid arthritis","volume":"74","author":"Fischer","year":"1981","journal-title":"South Med J"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0212","first-page":"267","article-title":"Polymyositis induced by D-penicillamine","volume":"48","author":"Brousson","year":"1981","journal-title":"Rev Rhum Mal Osteoartic"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0213","first-page":"159","article-title":"D-penicillamine-induced polymyositis","volume":"25","author":"Wouters","year":"1982","journal-title":"Neth J Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0214","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/ard.41.6.617","article-title":"Multiple side effects of penicillamine therapy in one patient with rheumatoid arthritis","volume":"41","author":"Essigman","year":"1982","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0215","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3109\/03009748309099739","article-title":"Penicillamine-induced dermatomyositis. a case history","volume":"12","author":"Lund","year":"1983","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0216","doi-asserted-by":"crossref","first-page":"327","DOI":"10.7326\/0003-4819-98-3-327","article-title":"Fatal polymyositis in D-penicillamine-treated rheumatoid arthritis","volume":"98","author":"Doyle","year":"1983","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0217","first-page":"697","article-title":"[Polymyositis induced by D-penicillamine]","volume":"39","author":"Renier","year":"1984","journal-title":"Therapie"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0218","first-page":"143","article-title":"Neuromuscular disorders associated with D-penicillamine treatment for rheumatoid arthritis","volume":"5","author":"Devogelaer","year":"1985","journal-title":"Int J Clin Pharmacol Res"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0219","first-page":"123","article-title":"D-penicillamine-induced polymyositis occurring in patients with rheumatoid arthritis: a report of two cases and demonstration of a positive lymphocyte stimulation test to D-penicillamine. henry ford","volume":"34","author":"Matsumura","year":"1986","journal-title":"Hosp Med J"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152227_bib0220","first-page":"855","article-title":"Polymyositis induced by D-penicillamine treatment of rheumatoid arthritis: apropos of 2 cases with antinuclear antibodies","volume":"115","author":"Masson","year":"1986","journal-title":"Union Med Can"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0221","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/art.1780290416","article-title":"D-penicillamine-induced polymyositis in patients with rheumatoid arthritis","volume":"29","author":"Takahashi","year":"1986","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0222","first-page":"995","article-title":"Penicillamine induced polymyositis and dermatomyositis","volume":"14","author":"Carroll","year":"1987","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0223","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-4362.1991.tb04231.x","article-title":"Cutaneous Problems with Drug Therapy in Rheumatoid Arthritis","volume":"30","author":"Wilson","year":"1991","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0224","first-page":"341","article-title":"Dermatopolymyositis induced by D-penicillamine in rheumatoid polyarthritis. a propos of 1 case with review of the literature","volume":"59","author":"Kolsi","year":"1992","journal-title":"Rev Rhum Mal Osteoartic"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0225","first-page":"207","article-title":"Neuromuscular complications of D-penicillamine in rheumatoid arthritis","volume":"148","author":"Dubost","year":"1992","journal-title":"Rev Neurol (Paris)"},{"issue":"19","key":"10.1016\/j.semarthrit.2023.152227_bib0226","first-page":"887","article-title":"D-penicillamine and dermatopolymyositis. value of the study of anti-JO 1 antibodies","volume":"15","author":"Oberlin","year":"1986","journal-title":"Presse Medicale Paris Fr 1983"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152227_bib0227","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/rheumatology\/32.12.1109","article-title":"D-penicillamine and polymyositis: the significance of the anti-Jo-1 antibody","volume":"32","author":"Jenkins","year":"1993","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0228","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF02229870","article-title":"D-penicillamine induced polymyositis causing complete heart block","volume":"13","author":"Wright","year":"1994","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0229","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF02231694","article-title":"D-penicillamine-induced myositis in rheumatoid arthritis","volume":"15","author":"Chappel","year":"1996","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0230","first-page":"153","article-title":"D-penicillamine-induced pemphigus, polymyositis and myasthenia","volume":"126","author":"Jan","year":"1999","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0231","series-title":"Rheumaderm","first-page":"187","article-title":"Dermatomyositis and drugs","author":"Dourmishev","year":"1999"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0232","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jaad.2008.05.034","article-title":"Dermatomyositis induced by drug therapy: a review of case reports","volume":"59","author":"Seidler","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0233","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2340\/0001555559543544","article-title":"Dermatomyositis induced by penicillamine","volume":"59","author":"Simpson","year":"1979","journal-title":"Acta Derm Venereol"},{"issue":"11","key":"10.1016\/j.semarthrit.2023.152227_bib0234","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/oxfordjournals.eurheartj.a059417","article-title":"Penicillamine-induced polymyositis with complete heart block","volume":"10","author":"Christensen","year":"1989","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152227_bib0235","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/rheumatology\/keg388","article-title":"Polymyositis associated with infliximab treatment for rheumatoid arthritis","volume":"42","author":"Musial","year":"2003","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0236","first-page":"136","article-title":"Orbital myositis in a rheumatoid arthritis patient during etanercept treatment","volume":"21","author":"Caramaschi","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0237","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3109\/s10165-006-0523-1","article-title":"Polymyositis associated with infliximab treatment for rheumatoid arthritis","volume":"16","author":"Urata","year":"2006","journal-title":"Mod Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0238","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/art.22358","article-title":"Evolution of dermatomyositis during therapy with a tumor necrosis factor \u03b1 inhibitor","volume":"55","author":"Hall","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0239","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/03009740701281293","article-title":"Severe polymyositis and flare in autoimmunity following treatment with adalimumab in a patient with overlapping features of polyarthritis and scleroderma","volume":"36","author":"Liozon","year":"2007","journal-title":"Scand J Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152227_bib0240","first-page":"2074","article-title":"Neuromuscular involvement in rheumatic patients treated with anti-tumor necrosis factor therapy\u2013three examples","volume":"35","author":"Kiltz","year":"2008","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0241","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10067-009-1370-1","article-title":"Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature","volume":"29","author":"Ishikawa","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0242","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10067-010-1661-6","article-title":"Is dermatomyositis in patients with rheumatoid arthritis induced by anti-TNF-\u03b1 therapy?","volume":"30","author":"Brunasso","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0243","article-title":"Lupus myositis with normal creatinine kinase levels following adalimumab use in a rheumatoid arthritis patient","author":"Almoallom","year":"2011","journal-title":"Archives of Rheumatology"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0244","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jbspin.2014.03.003","article-title":"Acute ocular myositis occurring under etanercept for rheumatoid arthritis","volume":"81","author":"Couderc","year":"2014","journal-title":"Joint Bone Spine"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152227_bib0245","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3899\/jrheum.111230","article-title":"Idiopathic orbital inflammation successfully treated using rituximab in a patient with rheumatoid arthritis: figure 1","volume":"39","author":"Ibrahim","year":"2012","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0246","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.alit.2017.09.001","article-title":"A case of clinically amyopathic dermatomyositis that developed during anti-TNF-\u03b1 therapy for rheumatoid arthritis","volume":"67","author":"Takata","year":"2018","journal-title":"Allergol Int"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0247","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/IJGM.S154835","article-title":"Nephritis, cerebritis, and myositis after adalimumab therapy in a patient with rheumatoid arthritis: a case report","volume":"11","author":"Omran","year":"2018","journal-title":"Int J Gen Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0248","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/24725625.2019.1628427","article-title":"A case of granulomatous myositis in a patient with rheumatoid arthritis receiving anti-TNF-\u03b1 treatment","volume":"4","author":"Kawamura","year":"2020","journal-title":"Mod Rheumatol Case Rep"},{"issue":"90002","key":"10.1016\/j.semarthrit.2023.152227_bib0249","doi-asserted-by":"crossref","first-page":"30ii","DOI":"10.1136\/ard.62.suppl_2.ii30","article-title":"Survival during treatment with tumour necrosis factor blocking agents in rheumatoid arthritis","volume":"62","author":"Flendrie","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0250","doi-asserted-by":"crossref","first-page":"R666","DOI":"10.1186\/ar1724","article-title":"Dermatological conditions during TNF-\u03b1-blocking therapy in patients with rheumatoid arthritis: a prospective study","volume":"7","author":"Flendrie","year":"2005","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0251","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MD.0b013e318190f170","article-title":"A systematic review of the off-label use of biological therapies in systemic autoimmune diseases","volume":"87","author":"Ramos-Casals","year":"2008","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0252","first-page":"240","article-title":"[Antisynthetase (anti PL-7 antibody) syndrome presenting as a skin rash and exacerbation of interstitial pneumonia during treatment for rheumatoid arthritis]","volume":"48","author":"Ishiguro","year":"2010","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0253","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3109\/s10165-009-0181-1","article-title":"Leflunomide-induced polymyositis in a patient with rheumatoid arthritis","volume":"19","author":"Ochi","year":"2009","journal-title":"Mod Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0254","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/s10165-004-0325-2","article-title":"Anticyclic citrullinated peptide antibodies in patients with mixed connective tissue disease","volume":"14","author":"Takasaki","year":"2004","journal-title":"Mod Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2023.152227_bib0255","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1177\/0961203315580873","article-title":"Development of mixed connective tissue disease and Sj\u00f6gren's syndrome in a patient with trisomy X","volume":"24","author":"Fujimoto","year":"2015","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0256","first-page":"OD05","article-title":"A rare case of mixed connective tissue disease (MCTD) with intricate features of lupus, polymyositis and rheumatoid arthritis presenting with severe myositis","volume":"9","author":"Lokesh","year":"2015","journal-title":"J Clin Diagn Res"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152227_bib0257","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/anr.1780320918","article-title":"High-grade atrioventricular heart block in an adult with systemic lupus erythematosus: The association of nuclear RNP (U1 RNP) antibodies, a case report, and review of the literature","volume":"32","author":"Bilazarian","year":"1989","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0258","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1148\/124.3.613","article-title":"Mixed connective tissue disease: the spectrum of radiographic manifestations","volume":"124","author":"Udoff","year":"1977","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0259","first-page":"288","article-title":"Mixed connective tissue disease","volume":"132","author":"Prystowsky","year":"1980","journal-title":"West J Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0260","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF02031271","article-title":"Clinical profiles of patients with antibodies to nuclear ribonucleoprotein","volume":"3","author":"Calderon","year":"1984","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0261","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archderm.1987.01660290069018","article-title":"Clinical implications of ribonucleoprotein antibody","volume":"123","author":"Rasmussen","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0262","first-page":"412","article-title":"Mixed connective tissue disease\u2013clinical and immunological profile","volume":"49","author":"null","year":"2001","journal-title":"J Assoc Physicians India"},{"issue":"597","key":"10.1016\/j.semarthrit.2023.152227_bib0263","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1259\/0007-1285-50-597-620","article-title":"Mixed connective tissue disease\u2014clinical and radiological aspects of 20 cases","volume":"50","author":"O'Connell","year":"1977","journal-title":"Br J Radiol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0264","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/rheumatology\/29.5.345","article-title":"Patients with arthritis and anti-U1-RNP antibodies: a 10 year follow-up","volume":"29","author":"Piirainen","year":"1990","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0265","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","article-title":"Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)","volume":"52","author":"Sharp","year":"1972","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0266","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archinte.1976.03630040029007","article-title":"Antibodies to components of extractable nuclear antigen. Clinical characteristics of patients","volume":"136","author":"Farber","year":"1976","journal-title":"Arch Intern Med"},{"issue":"25","key":"10.1016\/j.semarthrit.2023.152227_bib0267","first-page":"1863","article-title":"[Sharp\u2019s syndrome: a new entity amongst the connective tissue diseases?]","volume":"4","author":"Kahn","year":"1975","journal-title":"Nouv Presse Med"},{"issue":"02","key":"10.1016\/j.semarthrit.2023.152227_bib0268","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1055\/s-0038-1639473","article-title":"Musculoskeletal manifestations of non-RA connective tissue diseases: scleroderma, systemic lupus erythematosus, still's disease, dermatomyositis\/polymyositis, sj\u00f6gren's syndrome, and mixed connective tissue disease","volume":"22","author":"Jacques","year":"2018","journal-title":"Semin Musculoskelet Radiol"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0269","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MD.0b013e31824d9cec","article-title":"Inflammatory myopathies with anti-ku antibodies: a prognosis dependent on associated lung disease","volume":"91","author":"Rigolet","year":"2012","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0270","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archneur.1966.00470160063008","article-title":"Sjogren\u2019s syndrome and late-life myopathy","volume":"15","author":"Fox","year":"1966","journal-title":"Arch Neurol"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152227_bib0271","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/art.1780351014","article-title":"Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations","volume":"35","author":"Oddis","year":"1992","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0272","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5070\/D3184355DQ","article-title":"Sclerodermatomyositis associated with severe arthritis","volume":"10","author":"Toll","year":"2004","journal-title":"Dermatol Online J"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0273","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3109\/s10165-009-0171-3","article-title":"Severe erosive arthropathy requiring surgical treatments in systemic lupus erythematosus","volume":"19","author":"Kitaori","year":"2009","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0274","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1186\/ar3550","article-title":"International cohort study of 73 anti-Ku-positive patients: association of p70\/p80 anti-Ku antibodies with joint\/bone features and differentiation of disease populations by using principal-components analysis","volume":"14","author":"Lakota","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0275","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1186\/ar4562","article-title":"Scleroderma-polymyositis overlap syndrome versus idiopathic polymyositis and systemic sclerosis: a descriptive study on clinical features and myopathology","volume":"16","author":"Bhansing","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.semarthrit.2023.152227_bib0276","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/0961203316640918","article-title":"Clinical and serological associations of autoantibodies to the Ku70\/Ku80 heterodimer determined by a novel chemiluminescent immunoassay","volume":"25","author":"Mahler","year":"2016","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0277","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/mus.880050112","article-title":"Lupus myositis","volume":"5","author":"Foote","year":"1982","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0278","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/ard.53.3.178","article-title":"Muscle biopsy abnormalities in systemic lupus erythematosus: correlation with clinical and laboratory parameters","volume":"53","author":"Lim","year":"1994","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152227_bib0279","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/0961203320918021","article-title":"Inflammatory myositis in systemic lupus erythematosus","volume":"29","author":"Bitencourt","year":"2020","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0280","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/0961203320988587","article-title":"Myositis in systemic lupus erythematosus","volume":"30","author":"Cotton","year":"2021","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152227_bib0281","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/rheumatology\/34.9.831","article-title":"Arthritis in scleroderma","volume":"34","author":"Misra","year":"1995","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152227_bib0282","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/rheumatology\/37.1.39","article-title":"Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis","volume":"37","author":"Jacobsen","year":"1998","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0283","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0404.1990.tb01601.x","article-title":"Neuropathy and myopathy in primary Sj\u00f6gren\u2019s syndrome: neurophysiological, immunological and muscle biopsy results","volume":"82","author":"Vrethem","year":"2009","journal-title":"Acta Neurol Scand"},{"issue":"22","key":"10.1016\/j.semarthrit.2023.152227_bib0284","first-page":"3252","article-title":"Clinical and prognostic characteristics of 573 cases of primary Sj\u00f6gren's syndrome","volume":"123","author":"Lin","year":"2010","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0285","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/rheumatology\/keaa257","article-title":"Refining myositis associated with primary Sj\u00f6gren\u2019s syndrome: data from the prospective cohort ASSESS","volume":"60","author":"Felten","year":"2021","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0286","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s10067-018-4031-4","article-title":"The prevalence and clinical significance of anti-PUF60 antibodies in patients with idiopathic inflammatory myopathy","volume":"37","author":"Zhang","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"4\u20135","key":"10.1016\/j.semarthrit.2023.152227_bib0287","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s10067-003-0715-4","article-title":"Inclusion body myositis in connective tissue disorders: case report and review of the literature","volume":"22","author":"Derk","year":"2003","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0288","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0889-857X(03)00017-6","article-title":"Musculoskeletal involvement in scleroderma","volume":"29","author":"Pope","year":"2003","journal-title":"Rheum Dis Clin N Am"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0289","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/00002281-200211000-00013","article-title":"Scleroderma overlap syndromes","volume":"14","author":"Pope","year":"2002","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0290","first-page":"68","article-title":"Imaging of joints in systemic lupus erythematosus","volume":"114","author":"Tani","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0291","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.rdc.2008.08.009","article-title":"Relationship of sj\u00f6gren's syndrome to other connective tissue and autoimmune disorders","volume":"34","author":"Theander","year":"2008","journal-title":"Rheum Dis Clin N Am"},{"issue":"24","key":"10.1016\/j.semarthrit.2023.152227_bib0292","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MD.0000000000000223","article-title":"An autoimmune myositis-overlap syndrome associated with autoantibodies to nuclear pore complexes: description and long-term follow-up of the anti-nup syndrome","volume":"93","author":"Sen\u00e9cal","year":"2014","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0293","first-page":"329","article-title":"Nucleoporin p62 antibodies in a case of mixed connective tissue disease","volume":"10","author":"Kraemer","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0294","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2018.05.010","article-title":"Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies","volume":"140","author":"Yamaguchi","year":"2018","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0295","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jbspin.2014.01.005","article-title":"An arthro-dermato-pulmonary syndrome associated with anti-MDA5 antibodies","volume":"81","author":"Goussot","year":"2014","journal-title":"Joint Bone Spine"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152227_bib0296","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00296-018-3991-7","article-title":"Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review","volume":"38","author":"Gonz\u00e1lez-Moreno","year":"2018","journal-title":"Rheumatol Int"},{"issue":"8","key":"10.1016\/j.semarthrit.2023.152227_bib0297","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s10067-017-3671-0","article-title":"Hypomyopathic dermatomyositis associated with interstitial lung disease and good response to mycophenolate mofetil: case-based review","volume":"36","author":"Koyama","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152227_bib0298","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2169\/internalmedicine.1613-18","article-title":"Rheumatoid arthritis complicated with anti-melanoma differentiation-associated gene 5 antibody-positive interstitial pneumonia","volume":"58","author":"Matsumoto","year":"2019","journal-title":"Intern Med"},{"key":"10.1016\/j.semarthrit.2023.152227_bib0299","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.576436","article-title":"Fulminant course of neuromyelitis optica in a patient with anti-MDA5 antibody-positive Dermatomyositis: a case report","volume":"7","author":"Kang","year":"2020","journal-title":"Front Med"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152227_bib0300","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/1529-0131(199707)40:7<1257::AID-ART10>3.0.CO;2-R","article-title":"Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies","volume":"40","author":"Hausmanowa-Petrusewicz","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152227_bib0301","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10067-010-1467-6","article-title":"Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment?","volume":"29","author":"Nagashima","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152227_bib0302","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.100947","article-title":"Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy","volume":"38","author":"Nagashima","year":"2011","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152227_bib0303","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/rheumatology\/kep065","article-title":"Anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with idiopathic inflammatory myopathy","volume":"48","author":"Labrador-Horrillo","year":"2009","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152227_bib0304","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1172\/JCI106502","article-title":"Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy","volume":"50","author":"Sharp","year":"1971","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152227_bib0305","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/S0049-0172(03)00133-1","article-title":"Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single center","volume":"33","author":"Font","year":"2004","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152227_bib0306","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/art.1780311017","article-title":"A novel autoantibody causing a peripheral fluorescent antinuclear antibody pattern is specific for nuclear pore complexes","volume":"31","author":"Dagenais","year":"1988","journal-title":"Arthritis Rheum"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017223000690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017223000690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:11:34Z","timestamp":1758733894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017223000690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":306,"alternative-id":["S0049017223000690"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152227","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Joint and muscle inflammatory disease: A scoping review of the published evidence","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152227"}}